We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $832M
1-Year Est. Return 32.38%
This Fund
S&P 500
This Quarter Est. Return
+1.39%
1 Year Est. Return
+32.38%
3 Year Est. Return
+137.31%
5 Year Est. Return
+86.76%
10 Year Est. Return
AUM
$10.1B
AUM Growth
-$2.46B
Cap. Flow
-$2.33B
Cap. Flow %
-23.06%
Top 10 Hldgs %
66.26%
Holding
108
New
13
Increased
9
Reduced
29
Closed
17

Top Sells

Rank Stock Value
1
JD icon
JD.com
JD
+$864M
2
ZM icon
Zoom
ZM
+$370M
3
TAL icon
TAL Education Group
TAL
+$290M
4
UBER icon
Uber
UBER
+$274M
5
BILI icon
Bilibili
BILI
+$249M

Sector Composition

Rank Sector Weight
1 Healthcare 42.96%
2 Consumer Discretionary 20.09%
3 Technology 16.32%
4 Communication Services 9.51%
5 Financials 5.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYTK icon
76
Cytokinetics
CYTK
$10.1B
$5.37M 0.05%
230,718
MAACU
77
DELISTED
Montes Archimedes Acquisition Corp. Unit
MAACU
$5.1M 0.05%
500,000
NIO icon
78
NIO
NIO
$9.2B
$4.96M 0.05%
+127,200
New +$6.48M
CVET
79
DELISTED
Covetrus, Inc. Common Stock
CVET
$4.65M 0.05%
155,124
NTES icon
80
NetEase
NTES
$74B
$4.49M 0.04%
+43,500
New +$4.92M
SFUN
81
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$4.1M 0.04%
327,920
+297,920
+993% +$3.86M
RXDX
82
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$3.65M 0.04%
+200,000
New +$4.13M
YSG
83
Yatsen Holding
YSG
$249M
$3.1M 0.03%
50,153
-350,713
-87% -$31.9M
UXIN
84
Uxin Ltd
UXIN
$253M
$2.69M 0.03%
22,973
DGNR.U
85
DELISTED
Dragoneer Growth Opportunities Corp. Units, each consisting of one Class A ordinary share, and one-f
DGNR.U
$2.08M 0.02%
200,000
RCUS icon
86
Arcus Biosciences
RCUS
$3.06B
$1.4M 0.01%
50,000
-575,000
-92% -$20M
EDU icon
87
New Oriental
EDU
$8.88B
$1.1M 0.01%
+7,877
New +$1.38M
MRUS
88
DELISTED
Merus
MRUS
$972K 0.01%
46,532
-553,468
-92% -$12.8M
TCRR
89
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$874K 0.01%
39,577
-283,326
-88% -$7.72M
CIH
90
DELISTED
China Index Holdings Limited American Depository Shares
CIH
$654K 0.01%
300,000
LEAP.U
91
DELISTED
Ribbit LEAP, Ltd. Units, each consisting of one Class A Ordinary Share, and one fifth of one Warrant
LEAP.U
$550K 0.01%
50,000
ABCL icon
92
AbCellera Biologics
ABCL
$3.62B
-600,000
Closed -$24.1M
ALGN icon
93
Align Technology
ALGN
$10.9B
-182,283
Closed -$97.4M
AVIR icon
94
Atea Pharmaceuticals
AVIR
$426M
-125,000
Closed -$5.22M
CVAC
95
DELISTED
CureVac
CVAC
-51,199
Closed -$4.15M
FUTU icon
96
Futu Holdings
FUTU
$15.6B
-150,000
Closed -$6.86M
MELI icon
97
Mercado Libre
MELI
$96.3B
-27,525
Closed -$46.1M
SE icon
98
Sea Limited
SE
$66.6B
-337,622
Closed -$67.2M
TAL icon
99
TAL Education Group
TAL
$6.55B
-4,055,722
Closed -$290M
TXG icon
100
10x Genomics
TXG
$9.13B
-75,000
Closed -$10.6M

Similar funds

HHLR Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, HHLR Advisors held 108 positions worth $10.1B, down 20% from $12.6B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

HHLR Advisors withdrew a net $2.33B in Q1 2021, closing 17 positions and reducing 29 holdings. Its most notable exit was TAL Education Group, an estimated $290M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, HHLR Advisors opened a new position in Playtika worth $89.3M.

  • HHLR Advisors's largest Q1 2021 buy was Playtika: 3,280,699 shares worth $89.3M.
  • HHLR Advisors added most to NovaBridge Biosciences American Depositary Shares in Q1 2021, an estimated $278M increase.
  • HHLR Advisors's biggest Q1 2021 reduction was JD.com, cutting an estimated $864M.
  • HHLR Advisors fully exited TAL Education Group in Q1 2021, selling an estimated $290M.
  • HHLR Advisors's ten largest holdings make up 66% of its $10.1B portfolio in Q1 2021.
  • HHLR Advisors opened 13 new positions and closed 17 in Q1 2021.
  • HHLR Advisors's portfolio value fell 20% quarter-over-quarter to $10.1B.

Based on HHLR Advisors's 13F filing for Q1 2021, filed 17 May 2021.